Evidence
Am J Physiol Endocrinol Metab. 2024 Mar 20. doi: 10.1152/ajpendo.00260.2023. Online ahead of print.
ABSTRACT
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with increasing prevalence worldwide. NAFLD could develop from simple hepatic steatosis to non-alcoholic steatohepatitis (NASH) causing fibrosis, cirrhosis and even hepatocellular carcinoma. However, the mechanism of NAFLD development was still not be fully defined. Recently, there are emerging evidence showing the dysregulated iron metabolism with elevated serum ferritin and ferroptosis are involved in the NAFLD. The iron metabolism and ferroptosis would shed some light on the mechanisms of NAFLD development. Here, we summarized the studies concerning iron metabolism and ferroptosis process involving in NAFLD development to highlight the potential medicament and therapies in treating NAFLD.
PMID:38506752 | DOI:10.1152/ajpendo.00260.2023
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
🌐 90 Days
VR Related Evidence Matrix
- Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease
- Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
- Bacteroides and NAFLD: pathophysiology and therapy
- Role of the angiopoietin-like protein family in the progression of NAFLD
- The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review
- MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
- Metabolic study of iron deposition based on magnetic resonance in patients with nonalcoholic fatty liver disease
- Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat diet
- Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
- Emerging roles of RNA-binding proteins in fatty liver disease
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Berberine prevents NAFLD and HCC by modulating metabolic disorders
- Anthocyanin: A Potential Phytochemical Candidate for the Amelioration of Non-Alcoholic Fatty Liver Disease
- Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
- Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation
- Atorvastatin on Treatment of Nonalcoholic Fatty Liver Disease Patients
- Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review
- Lian-Mei-Yin formula alleviates diet-induced hepatic steatosis by suppressing Yap1/FOXM1 pathway-dependent lipid synthesis
- Targeted platelet with hydrogen peroxide responsive behavior for non-alcoholic steatohepatitis detection
- Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
- Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children's Hospital of Eastern Ontario grossing protocol
- Chronic exposure to ambient air pollution and the risk of non-alcoholic fatty liver disease: A cross-sectional study in Taiwan and Hong Kong
- THE GLOBAL EPIDEMIOLOGY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 DIABETES
- NAFLD and NASH: etiology, targets and emerging therapies
- Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
- Costunolide attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease
- Associations of arsenic exposure and arsenic metabolism with the risk of non-alcoholic fatty liver disease
- Semaglutide alters gut microbiota and improves NAFLD in db/db mice
- Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update
- Polysaccharide from Panax japonicus C.A. Mey prevents non-alcoholic fatty liver disease development based on regulating liver metabolism and gut microbiota in mice
- Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes
- Exercise ameliorates lipid droplet metabolism disorder by the PLIN2-LIPA axis-mediated lipophagy in mouse model of non-alcoholic fatty liver disease
- Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study
- Bacteroides fragilis aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota
- The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease
- Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma
- Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease
- Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease
- The role of Sirtuin 2 in liver - An extensive and complex biological process
- Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
- Occult liver disease: a multinational perspective
- The role of endoplasmic reticulum stress-related genes in the diagnosis and subtyping of non-alcoholic fatty liver disease
- Quantitative assessment of inflammation and evaluation of spatial heterogeneity for non-alcoholic fatty liver disease in mice based on iron-adjustive T1
- Relation between non-alcoholic fatty liver disease and carotid artery intimal media thickness as a surrogate for atherosclerosis: a systematic review and meta-analysis
- Chronic exposure to 3,6-dichlorocarbazole exacerbates non-alcoholic fatty liver disease in zebrafish by disrupting lipid metabolism and inducing special lipid biomarker accumulation
- Compare the Combined Diagnostic Accuracy of Transient Elastography and Visual Liver Score in Assessing Non-Alcoholic Fatty Liver Disease (NAFLD) and Compare it with Liver Biopsy in Morbidly Obese Patients Undergoing Bariatric Surgery: An…
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation
- Time-Restricted Feeding Ameliorates Methionine-Choline Deficient Diet-Induced Steatohepatitis in Mice
- Chronic exposure to parabens promotes non-alcoholic fatty liver disease in association with the changes of the gut microbiota and lipid metabolism
- In Vitro to In Vivo Scalars for Drug Clearance in Non-Alcoholic Fatty Liver and Steatohepatitis
- Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study
- Neutrophils: tissue and circulating signatures of pediatric non-alcoholic fatty liver disease
- TET3 boosts hepatocyte autophagy and impairs non-alcoholic fatty liver disease by increasing ENPP1 promoter hypomethylation
- Role of autophagy in betaine-promoted hepatoprotection against non-alcoholic fatty liver disease in mice
- Links between gut microbiome, metabolome, clinical variables and non-alcoholic fatty liver disease severity in bariatric patients
- Human umbilical cord mesenchymal stem cells attenuate diet-induced obesity and NASH-related fibrosis in mice
Evidence Blueprint
Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
🌐 365 Days
VR Related Evidence Matrix
- Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease
- Selective autophagy associated with iron overload aggravates non-alcoholic steatohepatitis via ferroptosis
- Inhibition of free heme-catalyzed Fenton-like reaction prevents non-alcoholic fatty liver disease by hepatocyte-targeted hydrogen delivery
- Dissecting the potential role of ferroptosis in liver diseases: an updated review
- Melatonin Ameliorates Hepatic Ferroptosis in NAFLD by Inhibiting ER Stress via the MT2/cAMP/PKA/IRE1 Signaling Pathway
- Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD
- Comprehensive analysis of epigenetic and epitranscriptomic genes' expression in human NAFLD
- Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosis
- Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
- Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
- Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies
- Corrected and republished from: Metabolic associated liver disease
- Bacteroides and NAFLD: pathophysiology and therapy
- Iron status and non-alcoholic fatty liver disease: A Mendelian randomization study
- Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease
- Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention
- Why do some glucose-lowering agents improve non-alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis
- Non-alcoholic fatty liver disease in women - Current knowledge and emerging concepts
- Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
- Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
- Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
- Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease
- Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
- Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation
- The role of ferroptosis in metabolic diseases
- Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
- Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease
- TIME-RESTRICTED FEEDING COMBINED WITH RESISTANCE EXERCISE TRAINING PREVENTS OBESITY AND IMPROVES LIPID METABOLISM IN THE LIVER OF MICE FED A HIGH-FAT DIET
- Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals
- Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances
- Liver fat as risk factor of hepatic and cardiometabolic diseases
- Role of the angiopoietin-like protein family in the progression of NAFLD
- Current, emerging, and potential therapies for non-alcoholic steatohepatitis
- Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives
- Changing epidemiology, global trends and implications for outcomes of NAFLD
- Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review
- The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review
- Melatonin targets ferroptosis through bimodal alteration of redox environment and cellular pathways in NAFLD model
- MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
- Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
- Metabolic study of iron deposition based on magnetic resonance in patients with nonalcoholic fatty liver disease
- Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat diet
- Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
- High-cholesterol diet in combination with hydroxypropyl-beta-cyclodextrin induces NASH-like disorders in the liver of rats
- Dissecting the role of cadmium, lead, arsenic, and mercury in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
- Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y
- Emerging roles of RNA-binding proteins in fatty liver disease
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Berberine prevents NAFLD and HCC by modulating metabolic disorders
- Anthocyanin: A Potential Phytochemical Candidate for the Amelioration of Non-Alcoholic Fatty Liver Disease
- Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
- Highland barley β-glucan supplementation attenuated hepatic lipid accumulation in Western diet-induced non-alcoholic fatty liver disease mice by modulating gut microbiota
- Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation
- Atorvastatin on Treatment of Nonalcoholic Fatty Liver Disease Patients
- Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease
- Glucosinolates Extracts from Brassica juncea Ameliorate HFD-Induced Non-Alcoholic Steatohepatitis
- Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review
- Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients
- Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD